Literature DB >> 12935784

Melanocyte-specific cell mediated immune response in vitiliginous Smyth line chickens.

X Wang1, G F Erf.   

Abstract

Smyth line chickens (SL) are an animal model to study human autoimmune vitiligo. Vitiligo in SL chickens is characterized by a post-hatch loss of feather melanocytes (MC) resulting in feather depigmentation. The etiopathology of this disease remains unclear, however, a hypothesis that cell-mediated immunity (CMI) plays an important role in the destruction of melanocytes has been proposed based on previous studies. To support this hypothesis, the delayed wattle response (DWR) to MC lysates was examined in SL chickens and normally pigmented, MHC-matched controls (Brown line, BL; Light Brown Leghorn, LBL) to determine whether vitiliginous SL chickens have MC-specific CMI. Chickens were challenged in one wattle with a lysate of either embryo- or feather-derived cultured MC. Lysates of chick-embryo-fibroblasts (CEF) associated turkey herpesvirus (HVT) vaccine and syngeneic CEF were used as positive and negative control, respectively. Vitiliginous SL chickens exhibited a significantly greater DWR to feather-MC but not to embryo-MC and CEF than nonvitiliginous SL chickens and normally pigmented controls. The DWR to feather-MC peaked at 3 to 5 days post feather-MC lysate injection. Immunohistochemical staining of DWR-positive wattle tissue revealed extensive lymphocyte infiltration at the site of feather-MC injection consisting primarily of T cells (TCR2+, CD4+ or CD8+ T cells). These observations support the presence of MC-specific CMI in SL chickens with vitiligo. The anti-MC CMI activity appears to be specific to MC derived from feathers. SDS-PAGE analysis of different sources of MC lysates revealed a 43 kDa missing band in the lysate of feather-MC established from SL chickens. No other obvious protein pattern differences that could account for the feather MC-specific CMI response in vitiliginous SL chickens were observed among the MC lysates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12935784     DOI: 10.1016/s0896-8411(03)00087-8

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  7 in total

1.  The growing feather as a dermal test site: Comparison of leukocyte profiles during the response to Mycobacterium butyricum in growing feathers, wattles, and wing webs.

Authors:  G F Erf; I R Ramachandran
Journal:  Poult Sci       Date:  2016-04-14       Impact factor: 3.352

2.  IFN-γ, IL-21, and IL-10 co-expression in evolving autoimmune vitiligo lesions of Smyth line chickens.

Authors:  Fengying Shi; Gisela F Erf
Journal:  J Invest Dermatol       Date:  2011-11-24       Impact factor: 8.551

3.  Understanding mechanisms of vitiligo development in Smyth line of chickens by transcriptomic microarray analysis of evolving autoimmune lesions.

Authors:  Fengying Shi; Byung-Whi Kong; Joon Jin Song; Jeong Yoon Lee; Robert L Dienglewicz; Gisela F Erf
Journal:  BMC Immunol       Date:  2012-04-13       Impact factor: 3.615

Review 4.  Recent Progress and Future Directions: The Nano-Drug Delivery System for the Treatment of Vitiligo.

Authors:  Ming-Chen Sun; Xiao-Ling Xu; Xue-Fang Lou; Yong-Zhong Du
Journal:  Int J Nanomedicine       Date:  2020-05-08

5.  Immune Activities in Choroids of Visually Impaired Smyth Chickens With Autoimmune Vitiligo.

Authors:  Jordan Sorrick; Wilson Huett; Kristen A Byrne; Gisela F Erf
Journal:  Front Med (Lausanne)       Date:  2022-04-25

Review 6.  Avian models with spontaneous autoimmune diseases.

Authors:  Georg Wick; Leif Andersson; Karel Hala; M Eric Gershwin; Carlo Selmi; Gisela F Erf; Susan J Lamont; Roswitha Sgonc
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

7.  Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin.

Authors:  Richard Yu; Raewyn Broady; Yuanshen Huang; Yang Wang; Jie Yu; Min Gao; Megan Levings; Shencai Wei; Shengquan Zhang; Aie Xu; Mingwan Su; Jan Dutz; Xuejun Zhang; Youwen Zhou
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.